Let’s forget about listing calories on menus and list the time it takes to burn the calories that you are about to order and eat. What if we listed the number of steps or the time needed to burn the calories you are about to eat rather than the calories …

What are the effects of using a GLP-1 drug when on the Atkins diet and a low-fat diet? Who are the best candidates for using a GLP-1 drug? Can GLP-1 drugs reduce apoptosis and increase betacell regeneration? Our publisher, Steve Freed, asks these questions and much more of Dr. David …

This week, we present the second half of our publisher Steve Freed’s interview with Dr. Steven Edelman at the recent ADA Scientific Sessions in San Diego. Steve Freed: One of the more exciting things I have read about is the extra eyelet effect on the GLP-1 compounds on the heart …

Our publisher, Steve Freed, sat down with Dr. Steven Edelman at the ADA Scientific Sessions in San Diego, and asked, “When should we add the GLP-1 drugs in the progression of diabetes?” and “How comfortable are you with the safety of the GLP-1 drugs?” … Steve Freed:  Thanks for taking …

This week, after our publisher Steve Freed was able to connect up with Dr. Vinik again, we bring you more insight on the latest in GLP-1 therapy.  I asked Dr. Vinik , “Who is the ideal type 2 patient for GLP-1 treatment?” and “Can GLP-1 drugs prevent apoptosis and regenerate …

Glucagon-like peptide-1 mimetics improve certain cardiovascular risk factors, although it is unclear if the observed benefits are direct effects or indirect effects due to weight loss. Improvements in systolic blood pressure seen in exenatide and liraglutide trials are illustrated in Figure 3. The decreases in systolic blood pressure range from …

One of the leading diabetes researchers in the world, Dr. Aaron I. Vinik leads the EVMS Strelitz Diabetes Center’s quest to cure diabetes. Internationally renowned for his research in the areas of hormone secreting tumors and the chronic complications of diabetes, Dr. Vinik has presented his work all over the world…. …

When our publisher, Steve Freed, BSPharm, and I first got together it was because I had found a soluble fiber product that lowered cholesterol levels and seemed to help control glucose levels. Steve explained that this fiber worked as a “bile acid sequestrant. Now he has found a whole class …

Treating to normal blood sugars may cause an increase in death. The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after …

With the current New England Journal Article on Avandia and it’s increased risks for cardiovascular problems, I believe we have missed the whole point of the article. Most people only looked at the editorials on the article and not the original article in the New England Journal of Medicine. If …